Interviews with the world’s key opinion leaders in cancer

Tagnew-generation androgen deprivation therapy drug sequencing

Responses to enzalutamide after prior abiraterone therapy in men with castration-resistant metastatic prostate cancer

February 11, 2014

SAN FRANCISCO— Four out of ten patients whose metastatic castration resistant prostate cancer had already been treated with abiraterone responded to...

Tagnew-generation androgen deprivation therapy drug sequencing

Responses to enzalutamide after prior abiraterone therapy in men with castration-resistant metastatic prostate cancer

Menu